Companies / Financials
IBKR
Interactive Brokers
Investment Banking & Brokerage
Investment Banking & BrokerageAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health82
Growth93
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control53
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)14.4%Revenue growth (FY)23.4%Revenue CAGR (3y)17.5%Gross margin—Operating margin—Net margin178.6%Free cash flow margin648.0%R&D / revenue—Stock comp / revenue4.8%Net debt / operating cash flow—Current ratio—Diluted share count change1.8%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.5B | $1.6B | $2.0B | $2.4B |
| Net income | $1.6B | $1.8B | $2.8B | $3.4B | $4.4B |
| Operating cash flow | $5.9B | $4.0B | $4.5B | $8.7B | $15.8B |
| Free cash flow | $5.9B | $4.0B | $4.5B | $8.7B | $15.8B |
| Stock-based comp | $80M | $92M | $100M | $112M | $118M |
| Dividends | $38M | $40M | $42M | $92M | $134M |
| Cash | $2.4B | $3.4B | $3.8B | $3.6B | $5.0B |
| Equity | $2.4B | $2.8B | $3.6B | $4.3B | $5.4B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.